Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine.
Giani T, Antonelli A, Sennati S, Di Pilato V, Chiarelli A, Cannatelli A, Gatsch C, Luzzaro F, Spanu T, Stefani S, Rossolini GM. Giani T, et al. Among authors: di pilato v. J Antimicrob Chemother. 2020 Apr 1;75(4):979-983. doi: 10.1093/jac/dkz547. J Antimicrob Chemother. 2020. PMID: 31958125
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience.
Giacobbe DR, Crea F, Morici P, Magnasco L, Di Pilato V, Briano F, Willison E, Pincino R, Dettori S, Tutino S, Esposito S, Coppo E, Dentone C, Portunato F, Mikulska M, Robba C, Vena A, Battaglini D, Brunetti I, Ball L, Pelosi P, Marchese A, Bassetti M. Giacobbe DR, et al. Among authors: di pilato v. Antibiotics (Basel). 2022 Dec 15;11(12):1823. doi: 10.3390/antibiotics11121823. Antibiotics (Basel). 2022. PMID: 36551480 Free PMC article.
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.
Pollini S, Fiscarelli E, Mugnaioli C, Di Pilato V, Ricciotti G, Neri AS, Rossolini GM. Pollini S, et al. Among authors: di pilato v. Clin Microbiol Infect. 2011 Aug;17(8):1272-5. doi: 10.1111/j.1469-0691.2011.03466.x. Epub 2011 Mar 7. Clin Microbiol Infect. 2011. PMID: 21375657 Free article.
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
Cannatelli A, D'Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, Gaibani P, Rossolini GM. Cannatelli A, et al. Among authors: di pilato v. Antimicrob Agents Chemother. 2013 Nov;57(11):5521-6. doi: 10.1128/AAC.01480-13. Epub 2013 Aug 26. Antimicrob Agents Chemother. 2013. PMID: 23979739 Free PMC article.
In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.
Cannatelli A, Di Pilato V, Giani T, Arena F, Ambretti S, Gaibani P, D'Andrea MM, Rossolini GM. Cannatelli A, et al. Among authors: di pilato v. Antimicrob Agents Chemother. 2014 Aug;58(8):4399-403. doi: 10.1128/AAC.02555-14. Epub 2014 May 19. Antimicrob Agents Chemother. 2014. PMID: 24841267 Free PMC article.
MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.
Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, Vatopoulos A, Rossolini GM; COLGRIT Study Group. Cannatelli A, et al. Among authors: di pilato v. Antimicrob Agents Chemother. 2014 Oct;58(10):5696-703. doi: 10.1128/AAC.03110-14. Epub 2014 Jul 14. Antimicrob Agents Chemother. 2014. PMID: 25022583 Free PMC article.
108 results